CI Investments Inc’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,272
Closed -$38K 1348
2025
Q1
$38K Sell
1,272
-6
-0.5% -$229 ﹤0.01% 1068
2024
Q4
$51K Sell
1,278
-1,308
-51% -$49.5K ﹤0.01% 1038
2024
Q3
$88K Buy
2,586
+20
+0.8% +$563 ﹤0.01% 883
2024
Q2
$56K Buy
2,566
+477
+23% +$10K ﹤0.01% 953
2024
Q1
$46K Buy
2,089
+2
+0.1% +$49 ﹤0.01% 1030
2023
Q4
$57K Sell
2,087
-546
-21% -$13.2K ﹤0.01% 949
2023
Q3
$59K Sell
2,633
-78
-3% -$2.01K ﹤0.01% 938
2023
Q2
$69K Buy
2,711
+745
+38% +$18.1K ﹤0.01% 877
2023
Q1
$44K Sell
1,966
-25
-1% -$604 ﹤0.01% 934
2022
Q4
$47K Buy
1,991
+1,557
+359% +$36.2K ﹤0.01% 944
2022
Q3
$7K Sell
434
-33
-7% -$743 ﹤0.01% 1152
2022
Q2
$9K Buy
467
+170
+57% +$3.43K ﹤0.01% 1046
2022
Q1
$8K Buy
+297
New +$8.49K ﹤0.01% 1103

Other funds holding VCYT

CI Investments Inc's VCYT Position: Q2 2025 in Review

CI Investments Inc sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 1,272 shares — an estimated $38K sold.

CI Investments Inc first reported a position in VCYT in Q1 2022 and held it in 13 quarters. The position peaked at $88K in Q3 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • CI Investments Inc reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,272 Veracyte shares in Q2 2025, an estimated $38K.
  • CI Investments Inc first reported a position in Veracyte in Q1 2022 and held it in 13 quarters.
  • CI Investments Inc's Veracyte position peaked at $88K in Q3 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.